Lakefront Appoints Eric Hedrick, MD, as Chief Medical Officer
On June 8, 2026, at 22:01 CET in Mechelen, Belgium, Lakefront Bio therapeutics NV shared news of Dr. Eric Hedrick's appointment as Chief Medical Officer. This move aligns with the company's strategic shift after acquiring Ouro Medicines operational assets on June 4, 2026. Dr. Hedrick, MD, will now report to CEO Henry Gosebruch and become a member of the Management Committee. Lakefront Bio therapeutics NV, listed on Euronext & NASDAQ as LKFT, continues to focus on growth and transformation in its leadership structure.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments